Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-11 4:58 pm Purchase |
2021-02-03 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 1,900,000 5.300% |
1,900,000 (New Position) |
Filing History |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
The Vanguard Group | 1,845,962 5.130% |
1,845,962 (New Position) |
Filing History |
| 2020-12-03 4:47 pm Sale |
2020-11-23 | 13D | Black Diamond Therapeutics, Inc. BDTX |
Versant Venture Capital VI, L.P. | 4,328,883 12.000% |
-1,031,634 (-19.25%) |
Filing History |
| 2020-11-20 5:32 pm Sale |
2020-11-11 | 13D | Black Diamond Therapeutics, Inc. BDTX |
Versant Venture Capital VI, L.P. | 5,360,517 14.900% |
-980,734 (-15.47%) |
Filing History |
| 2020-09-25 4:37 pm Sale |
2020-09-17 | 13D | Black Diamond Therapeutics, Inc. BDTX |
Versant Venture Capital VI, L.P. | 6,341,251 17.700% |
-457,424 (-6.73%) |
Filing History |
| 2020-08-21 4:19 pm Sale |
2020-08-12 | 13D | Black Diamond Therapeutics, Inc. BDTX |
Versant Venture Capital VI, L.P. | 6,798,675 18.900% |
-669,608 (-8.97%) |
Filing History |